Scot Ebbinghaus
Attending Physician · Temple University Hospital
Credentials: · · · ·
History
Present
- 1992–1994
Medical Oncology
- 1989–1992
University
Research
Pembrolizumab versus Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2015 · 4,750 citations
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma
New England Journal of Medicine · 2013 · 2,799 citations
The Lancet Oncology · 2018 · 2,099 citations
16 papers
15 papers
14 papers
12 papers
- RJ
10 papers
- SK
10 papers
10 papers
9 papers
Grants
- 2002–2005
Site Specific Alkylation of the HER2/Neu Promoter
National Cancer Institute · R01
Contact PI · $970.5K · University of Arizona
- 1998–2002
Specific Inhibition of her2/Neu Transcription Elongation
National Cancer Institute · R29
Contact PI · $439.4K · University of Arizona
- 1996–1999
Triplex Based Gene Therapy of Breast and Ovarian Cancer
National Cancer Institute · K08
Contact PI · $236.5K · University of Alabama at Birmingham